Application of high-flux hemodialysis combined with hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of renal anemia in patients with uremia: A randomized controlled trial.

Medicine (Baltimore) · 2026 · PMC13313663 · PMID 42363494

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

[ 20 ] Although the incidence of adverse events was numerically higher in the HIF-PHI group, the difference did not reach statistical significance, which may be attributed to the limited sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.